These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 4644648

  • 1. Canadian experience.
    Cook D.
    Pharmacology; 1972; 8(1):190-8. PubMed ID: 4644648
    [No Abstract] [Full Text] [Related]

  • 2. Proceedings: The comparison of the bioavailabilities of commercial nitrofurantoin tablets.
    McGilveray IJ, Mattok GL, Hossie RD.
    Rev Can Biol; 1973; 32():Suppl:99-106. PubMed ID: 4777608
    [No Abstract] [Full Text] [Related]

  • 3. Comparative bioavailabilities from truncated blood level curves.
    Lovering EG, McGilveray IJ, McMillan I, Tostowaryk W.
    J Pharm Sci; 1975 Sep; 64(9):1521-4. PubMed ID: 1185570
    [Abstract] [Full Text] [Related]

  • 4. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E, Jamali F, Dryden W, Friesen E, Koven S, Mohamed I, Osmond B, Alessi-Severini S, Sheldon L, Sheldon R, Tam Y, Tsuyuki R, Zhanel G.
    J Pharm Pharm Sci; 1998 Sep; 1(1):2-7. PubMed ID: 10942966
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The importance of biopharmaceutics in pharmaceutical education.
    Mezei M.
    Pharmazie; 1971 Nov; 26(11):656-8. PubMed ID: 5154315
    [No Abstract] [Full Text] [Related]

  • 7. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract] [Full Text] [Related]

  • 8. Non-equivalent preparations of the same drug.
    Drug Ther Bull; 1971 Aug 13; 9(17):65-8. PubMed ID: 5123964
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determination of physiologic availability of commercial phenylbutazone preparations.
    Chiou WL.
    J Clin Pharmacol New Drugs; 1972 Jul 13; 12(7):296-300. PubMed ID: 4483535
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Canadian health ministry is given new powers to tighten drug safety.
    Dyer O.
    BMJ; 2014 Jun 24; 348():g4231. PubMed ID: 24962373
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Tolerance ansd effectiveness of a new nitrofurantoin dosage form in healthy subjects and patients with renal insufficiency].
    Lais J.
    Wien Med Wochenschr; 1971 Jul 10; 121(27):553-9. PubMed ID: 5002695
    [No Abstract] [Full Text] [Related]

  • 19. The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.
    Van Petten GR, Feng H, Withey RJ, Lettau HF.
    J Clin Pharmacol New Drugs; 1971 Jul 10; 11(3):177-86. PubMed ID: 5211351
    [No Abstract] [Full Text] [Related]

  • 20. Keeping bioavailability in perspective.
    Schumacher GE.
    Am J Hosp Pharm; 1973 Feb 10; 30(2):150-4. PubMed ID: 4690469
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.